IL13 and influenza: In a subset of individuals, the bacterially produced recombinant VLP-based influenza vaccine shifted pre-vaccination-induced type-2 cytokines such as IL-5 and IL-13 to a post-vaccination type-1 cytokine signature characterized by IFN-γ [44].